Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-Glucose Cotransporter 2 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03951805
What this trial is testing

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 205
Post-approval studies (Phase 4)Looking for participantsNCT04662723
What this trial is testing

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

Who this might be right for
GlomerulonephritisImmunoglobulin A Nephropathy
Fondazione Schena 878
Post-approval studies (Phase 4)Not Yet RecruitingNCT07527390
What this trial is testing

CANagliflozin In DIALysis Patients

Who this might be right for
DialysisChronic Kidney Disease (Stages 4 and 5)
University Medical Center Groningen 10
Post-approval studies (Phase 4)Active Not RecruitingNCT05590143
What this trial is testing

ProMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2

Who this might be right for
Acute Kidney InjuryCardiac SurgerySodium-Glucose Transporter 2 Inhibitor
Amsterdam UMC 784
Not applicableUnknownNCT06344247
What this trial is testing

Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

Who this might be right for
ObesityChronic Kidney Diseases
RenJi Hospital 48
Post-approval studies (Phase 4)Study completedNCT05621551
What this trial is testing

Dapagliflozin Therapy In Cardiac Surgery

Who this might be right for
Diabetes Mellitus, Type 2Cardiac Surgery
China National Center for Cardiovascular Diseases 178
Not applicableStudy completedNCT06903754
What this trial is testing

ISGLT2 in Patients Without DM With Acute MI

Who this might be right for
Acute Coronary SyndromesHeart Failure
Mohammed VI University Hospital 450
Post-approval studies (Phase 4)Ended earlyNCT02462421
What this trial is testing

Pharmacogenetics of SGLT2 Inhibitors

Who this might be right for
Diabetes MellitusGoutHyperuricemia
University of Maryland, Baltimore 30
Testing effectiveness (Phase 2)Looking for participantsNCT07174687
What this trial is testing

SGLT2 Inhibitors in Geographic Atrophy

Who this might be right for
Retinal DegenerationRetinal DiseasesEye Diseases+2 more
Washington University School of Medicine 70
Large-scale testing (Phase 3)UnknownNCT05776043
What this trial is testing

Empagliflozin and Dapagliflozin in Patients Hospitalized for Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
Medical University of Warsaw 1,364
Not applicableStudy completedNCT06951737
What this trial is testing

Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients

Who this might be right for
Diabetes MellitusAtrial Fibrillation (AF)
Bursa Postgraduate Hospital 120
Post-approval studies (Phase 4)Looking for participantsNCT07614230
What this trial is testing

SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Coronary Artery DiseaseAtherosclerosis
Junjie Yang 144
Early research (Phase 1)Active Not RecruitingNCT02891954
What this trial is testing

Genetics of Response to Canagliflozin

Who this might be right for
Diabetes Mellitus, Type 2
University of Maryland, Baltimore 700
Not applicableUnknownNCT05408936
What this trial is testing

SGLT2 Inhibitors and Effects on Hematopoiesis, Inflammation and Metabolic Markers

Who this might be right for
Diabetes Mellitus, Type 2
University of Patras 80
Testing effectiveness (Phase 2)Looking for participantsNCT07018622
What this trial is testing

Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity

Who this might be right for
Solid TumorsCisplatin Nephrotoxicity
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 46
Post-approval studies (Phase 4)Looking for participantsNCT06782139
What this trial is testing

Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity

Who this might be right for
Obesity and Type 2 Diabetes
Korea University Anam Hospital 30
Large-scale testing (Phase 3)UnknownNCT05505994
What this trial is testing

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders+2 more
Daewoong Pharmaceutical Co. LTD. 340
Testing effectiveness (Phase 2)UnknownNCT05914857
What this trial is testing

Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients

Who this might be right for
Prediabetic StateImpaired Fasting GlucoseImpaired Glucose Tolerance
Yangjin 120
Post-approval studies (Phase 4)Study completedNCT02397421
What this trial is testing

Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes

Who this might be right for
Heart FailureDiabetes
University of Dundee 56
Post-approval studies (Phase 4)Study completedNCT06383832
What this trial is testing

Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Diet.

Who this might be right for
OverweightCarbohydrateSodium-glucose Transporter 2 Inhibitors
Sun Jia 36
Next Page